Piramal Enterprises Ltd.
Snapshot View

847.60 +3.05 ▲0.4%

02 February 2023, 04:01:00 PM
Volume: 36,192

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.piramal.com
Market Cap 20,229.14 Cr.
Enterprise Value(EV) 32,317.78 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -3.17 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.44 Trailing Twelve Months Ending 2022-09
Book Value / Share 1,151.09 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.74 Calculated using Price: 847.60
Dividend Yield 3.89 Period Ending 2022-03
No. of Shares Subscribed 23.87 Cr. 238,663,700 Shares
FaceValue 2
Company Profile
Piramal Enterprises Limited (PEL) is one of India's leading diversified companies, with a presence in Financial Services and Pharmaceuticals. Driven by both organic as well as inorganic strategy, PEL has steered dynamic business growth over the three decades of its existence.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.36%
1 Week
+2.79%
1 Month
+1.25%
3 Month
+1.16%
6 Month
-50.99%
1 Year
-66.28%
2 Year
-43.58%
5 Year
-67.16%
10 Year
+55.67%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -4.96 25.55 5.76 7.78 23.36 4.26 -3.61 3.33 3.87
Return on Capital Employed (%) 3.30 18.70 7.19 8.96 8.52 7.93 8.00 10.03 7.71
Return on Assets (%) -2.01 10.59 2.35 2.46 7.62 1.41 -1.26 1.33 1.42

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 9,321 11,736 12,948 14,883 26,562 27,224 30,572 34,018 35,489 27,472
Non Curr. Liab. 6,710 7,817 11,760 18,776 25,355 29,033 24,454 34,163 50,386 1,266
Curr. Liab. 9,490 5,694 10,542 18,962 22,479 31,213 23,673 13,873 19,576 49,416
Minority Int. 29 0 13 12 9 1,121 1,348
Equity & Liab. 25,521 25,276 35,250 52,634 74,409 87,480 78,699 83,175 106,799 78,154
Non Curr. Assets 21,149 19,912 30,595 43,471 61,843 75,089 62,586 62,782 81,611 3,046
Curr. Assets 4,372 5,364 4,655 9,163 12,566 12,390 16,113 20,393 25,188 75,108
Misc. Exp. not W/O
Total Assets 25,521 25,276 35,250 52,634 74,409 87,480 78,699 83,175 106,799 78,154

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 4,503 5,123 6,342 8,504 10,631 13,215 13,068 12,809 13,993 13,421
Other Income 225 255 252 234 264 317 500 364 720 730
Total Income 4,728 5,377 6,593 8,737 10,895 13,532 13,569 13,173 14,713 14,151
Total Expenditure -3,868 -4,238 -4,649 -5,005 -5,476 -6,573 -6,810 -5,345 -7,543 -10,368
PBIDT 860 1,140 1,944 3,733 5,419 6,959 6,758 7,828 7,170 3,783
Interest -1,050 -511 -974 -2,031 -2,978 -4,100 -5,321 -4,209 -4,480 -4,646
Depreciation -247 -290 -255 -382 -477 -401 -520 -561 -666 -576
Taxation -63 -345 -50 -228 2,876 -861 -1,960 -2,043 -511 263
Exceptional Items 1 2,696 46 -10 -452 59 -168 452
PAT -498 2,690 711 1,082 4,840 1,145 -1,043 1,074 1,346 -724
Minority Interest -1 0 0 1 3 3 -81 -76 -64
Share Associate -3 159 194 170 280 319 490 338 653 712
Other Related Items
Consolidated Net Profit -501 2,850 905 1,252 5,121 1,467 24 1,332 1,923 -76
Adjusted EPS -28 160 51 70 277 78 1 59 81 -3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1,570 -1,604 -2,207 -6,956 -10,057 -15,967 -11,611 7,516 3,665 8,750
Cash Fr. Inv. -1,664 1,483 6,177 -604 -2,403 -1,768 -827 7,469 -2,772 -2,226
Cash Fr. Finan. 3,281 126 -3,865 7,544 13,570 18,650 10,752 -13,019 2,072 -6,988
Net Change 46 4 106 -16 1,111 916 -1,686 1,966 2,964 -465
Cash & Cash Eqvt 269 325 447 227 1,364 2,301 623 2,612 5,582 6,282

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 46.06 46.06 43.52 43.51 43.49 43.49 43.49 43.48 43.48
Public 53.94 53.94 56.48 56.49 56.51 56.51 56.51 56.50 56.52
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 02 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Thu, 02 Feb 2023
Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended - Receipt Of Request Seeking Re-Classification From 'Promoter Group' Category To 'Public' Category Of Piramal Enterprises Limited
Disclosure under Regulation 30 read with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended - Receipt of request seeking re-classification from Promoter Group category to Public category of Piramal Enterprises Limited
Wed, 01 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Technical Scans View Details >>

Thu, 02 Feb 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 6 Months High Decrease in 6 Months
High Decrease in 1 Year High Decrease in 1 Year
Closing Near 50 SMA Closing Near 50 SMA
Closing Near 100 SMA Closing Near 100 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,852.96 1,008.00 -0.6%
Divi's Laboratories Ltd. 86,732.57 3,271.90 -2.5%
Cipla Ltd. 82,728.22 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. 72,771.66 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. 60,864.05 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. 52,144.29 1,541.15 +0.5%
Zydus Lifesciences Ltd. 43,787.95 432.60 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.42 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.03 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 31.36 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.95 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.52 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.77 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.59 432.60 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.37 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 3.65 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.17 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.63 432.60 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 432.60 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 432.60 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 432.60 -0.7%

FAQ's On Piramal Enterprises Ltd.

What is Piramal Enterprises share price?

Can I buy Piramal Enterprises shares now?

What is the Dividend Yield of Piramal Enterprises?

What is the Market Cap of Piramal Enterprises?

What are the key metrics to analyse Piramal Enterprises?

What is the 52 Week High and Low of Piramal Enterprises?

What is the trend of Piramal Enterprises share price?